Liver disease remains a key contributor to morbidity and mortality among people with HIV.
Although substantial progress has been made in terms of a cure for hepatitis C, increased life expectancy is associated with emerging issues associated with steatotic liver disease.
Hepatitis B and D are still prevalent and often underrecognized as a cause of indolent liver injury leading to inflammation and fibrosis.
Barriers to care exist in many subpopulations that reduce the use of potentially lifesaving therapies.
Hepatocellular carcinoma continues to be a factor in advanced hepatic fibrosis.
